2024
Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia.
Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.
Aflatoxin B1 and Epstein Barr virus (EBV)-induced CCL22 expression stimulates B cell infection.
The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies
Role of IL-27 in Epstein–Barr virus infection revealed by IL-27RA deficiency.
Environmental risk factors of Wilms tumour: A systematic review and meta-analysis.
Cancer-Specific Epigenome Identifies Oncogenic Hijacking by Nuclear Factor I Family Proteins for Medulloblastoma Progression.
Integrative analysis of neuroblastoma by single‐cell RNA sequencing identifies the NECTIN2‐TIGIT axis as a target for immunotherapy.
2023
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
Association between Residential Proximity to Viticultural Areas and Childhood Acute Leukemia Risk in Mainland France: GEOCAP Case-Control Study, 2006-2013.
Risk factors for childhood brain tumours: a systematic review and meta-analysis of observational studies from 1976 to 2022.
Synthesized evidence for childhood acute lymphoblastic leukemia.
2021 et 2022
Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model.
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma.
Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors.
Epigenetic Alteration of the Cancer-Related Gene TGFBI in B Cells Infected with Epstein-Barr Virus and Exposed to Aflatoxin B1: Potential Role in Burkitt Lymphoma Development.
Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.
